These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23219287)

  • 1. Extended adjuvant tamoxifen for breast cancer--a new era?
    Powles TJ
    Lancet; 2013 Mar; 381(9869):782-3. PubMed ID: 23219287
    [No Abstract]   [Full Text] [Related]  

  • 2. New data refine role of adjuvant tamoxifen in early breast cancer.
    Am J Health Syst Pharm; 1996 Jan; 53(2):123-4. PubMed ID: 8653477
    [No Abstract]   [Full Text] [Related]  

  • 3. The Atlas trial: Tamoxifen for a longer duration for early breast cancer.
    Raina V
    Natl Med J India; 2013; 26(1):4-5. PubMed ID: 24066985
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer.
    Machin D; Andersen KW
    J Natl Cancer Inst; 1997 May; 89(9):659-60. PubMed ID: 9150193
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant tamoxifen: 5 year control of dormant disease?
    Merimsky O; Inbar M; Kovner F; Chaitchik S
    Eur J Cancer; 1996 Jan; 32A(1):174. PubMed ID: 8695228
    [No Abstract]   [Full Text] [Related]  

  • 6. Importance of long-term follow-up of women receiving adjuvant therapy for breast cancer in the community.
    McCowan C; Dewar JA; Thompson AM
    J Clin Oncol; 2011 Sep; 29(25):3492; author reply 3492; discussion 3492-3. PubMed ID: 21768466
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen therapy for patients with breast cancer.
    Huiart L; Ferdynus C; Giorgi R
    Lancet; 2013 Jun; 381(9883):2077. PubMed ID: 23769224
    [No Abstract]   [Full Text] [Related]  

  • 8. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen therapy for patients with breast cancer.
    Neven P; Joensuu H; Osborne K; Cardoso F; Loibl S; Linn S; Goldhirsch A; Ortmann O; Senn HJ; Hayes DF
    Lancet; 2013 Jun; 381(9883):2078. PubMed ID: 23769226
    [No Abstract]   [Full Text] [Related]  

  • 10. [For how long should breast cancer patients take Tamoxifen? The International Program ATLAS will answer this question].
    Semiglazov VF
    Vopr Onkol; 1998; 44(4):373-7. PubMed ID: 9807196
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of adjuvant endocrine therapy for postoperative breast cancer patients].
    Doihara H; Ogasawara Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():563-7. PubMed ID: 17682212
    [No Abstract]   [Full Text] [Related]  

  • 12. Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
    Ward JH
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):51-5. PubMed ID: 19952743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer.
    Van Asten K; Poppe A; Punie K; Jongen L; Lintermans A; Wildiers H; Neven P
    Curr Treat Options Oncol; 2015 Jul; 16(7):31. PubMed ID: 26031545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current adjuvant endocrine treatment of breast cancer].
    Dedes KJ; Gabriel N; Fink D
    Gynakol Geburtshilfliche Rundsch; 2008; 48(3):130-7. PubMed ID: 18566529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping tamoxifen after 5 years of therapy for early breast cancer: does it alter quality of life?
    Hall PS; Walkington JP; Cameron DA
    Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):652. PubMed ID: 21703830
    [No Abstract]   [Full Text] [Related]  

  • 16. Variation in use of adjuvant tamoxifen.
    Davies C; McGale P; Peto R
    Lancet; 1998 May; 351(9114):1487-8. PubMed ID: 9605808
    [No Abstract]   [Full Text] [Related]  

  • 17. Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.
    Jinih M; Relihan N; Corrigan MA; O'Reilly S; Redmond HP
    Breast J; 2017 Nov; 23(6):694-705. PubMed ID: 28252242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can endocrine treatment for hormone-positive premenopausal women with early breast cancer replace adjuvant chemotherapy?
    Malayeri R
    J Clin Oncol; 2003 Jun; 21(12):2444-5; author reply 2446-7. PubMed ID: 12805348
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of patients with hormone receptor-positive breast cancer who need adjuvant tamoxifen therapy for more than 5 years.
    Wu CE; Chen SC; Chang HK; Lo YF; Hsueh S; Lin YC
    J Formos Med Assoc; 2016 Apr; 115(4):249-56. PubMed ID: 25900861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine therapy for breast cancer: a tough pill to swallow.
    Reynolds KL; Higgins MJ
    Menopause; 2013 Jul; 20(7):714-6. PubMed ID: 23760435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.